168 related articles for article (PubMed ID: 11459123)
1. Possible roles of cardiac chymase after myocardial infarction in hamster hearts.
Jin D; Takai S; Yamada M; Sakaguchi M; Yao Y; Miyazaki M
Jpn J Pharmacol; 2001 Jun; 86(2):203-14. PubMed ID: 11459123
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of cardiac chymase inhibition during the acute phase of myocardial infarction.
Jin D; Takai S; Yamada M; Sakaguchi M; Miyazaki M
Life Sci; 2002 Jun; 71(4):437-46. PubMed ID: 12044843
[TBL] [Abstract][Full Text] [Related]
3. Impact of chymase inhibitor on cardiac function and survival after myocardial infarction.
Jin D; Takai S; Yamada M; Sakaguchi M; Kamoshita K; Ishida K; Sukenaga Y; Miyazaki M
Cardiovasc Res; 2003 Nov; 60(2):413-20. PubMed ID: 14613871
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent expression of chymase and angiotensin converting enzyme in the hamster heart under pressure overload.
Li P; Chen PM; Wang SW; Chen LY
Hypertens Res; 2002 Sep; 25(5):757-62. PubMed ID: 12452330
[TBL] [Abstract][Full Text] [Related]
5. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
6. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
[TBL] [Abstract][Full Text] [Related]
7. Chymase inhibitor improves survival in hamsters with myocardial infarction.
Hoshino F; Urata H; Inoue Y; Saito Y; Yahiro E; Ideishi M; Arakawa K; Saku K
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S11-8. PubMed ID: 12688390
[TBL] [Abstract][Full Text] [Related]
8. Increased angiotensin-converting enzyme activity in the left ventricle after infarction.
Busatto VC; Cicilini MA; Mill JG
Braz J Med Biol Res; 1997 May; 30(5):679-87. PubMed ID: 9283639
[TBL] [Abstract][Full Text] [Related]
9. High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium.
Ihara M; Urata H; Shirai K; Ideishi M; Hoshino F; Suzumiya J; Kikuchi M; Arakawa K
Cardiology; 2000; 94(4):247-53. PubMed ID: 11326146
[TBL] [Abstract][Full Text] [Related]
10. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
[TBL] [Abstract][Full Text] [Related]
11. Effect of an angiotensin II receptor antagonist, candesartan cilexetil, on canine intima hyperplasia after balloon injury.
Miyazaki M; Wada T; Shiota N; Takai S
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S21-5; discussion S33-4. PubMed ID: 10076917
[TBL] [Abstract][Full Text] [Related]
12. Roles of vascular angiotensin converting enzyme and chymase in two-kidney, one clip hypertensive hamsters.
Jin D; Takai S; Shiota N; Miyazaki M
J Hypertens; 1998 May; 16(5):657-64. PubMed ID: 9797177
[TBL] [Abstract][Full Text] [Related]
13. Cardiac remodeling and angiotensin II-forming enzyme activity of the left ventricle in hamsters with chronic pressure overload induced by ascending aortic stenosis.
Shimizu M; Tanaka R; Fukuyama T; Aoki R; Orito K; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):271-6. PubMed ID: 16598172
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of angiotensin-converting enzyme inhibition in adriamycin-induced cardiomyopathy in hamsters.
Okumura K; Jin D; Takai S; Miyazaki M
Jpn J Pharmacol; 2002 Feb; 88(2):183-8. PubMed ID: 11928719
[TBL] [Abstract][Full Text] [Related]
15. Tissue angiotensin II system in the human heart.
Urata H; Hoffmann S; Ganten D
Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
[TBL] [Abstract][Full Text] [Related]
16. Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.
Wei CC; Hase N; Inoue Y; Bradley EW; Yahiro E; Li M; Naqvi N; Powell PC; Shi K; Takahashi Y; Saku K; Urata H; Dell'italia LJ; Husain A
J Clin Invest; 2010 Apr; 120(4):1229-39. PubMed ID: 20335663
[TBL] [Abstract][Full Text] [Related]
17. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
18. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart.
Shiota N; Fukamizu A; Takai S; Okunishi H; Murakami K; Miyazaki M
J Hypertens; 1997 Apr; 15(4):431-40. PubMed ID: 9211178
[TBL] [Abstract][Full Text] [Related]
19. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
[TBL] [Abstract][Full Text] [Related]
20. An antiarrhythmic effect of a chymase inhibitor after myocardial infarction.
Jin D; Takai S; Sakaguchi M; Okamoto Y; Muramatsu M; Miyazaki M
J Pharmacol Exp Ther; 2004 May; 309(2):490-7. PubMed ID: 14730006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
